According to data from the TISCH database, it was firstly reported that YRDC expression was relatively higher in tumor cells than non‐tumor cell types in UVM, STAD, SKCM, OV, HNSC, BRCA, PAAD, NSCLC, and glioma. Here, YRDC is linked to pancreatic adenocarcinoma.